A federal judge has ruled that plaintiffs can continue to pursue off-label marketing claims against generic testosterone drug manufacturers, even though failure to warn claims are preempted.
Tag Archives: Testopel
Heart attack and stroke lawsuits filed against the makers of generic testosterone drugs have been dismissed on preemption grounds, including claims against Depo-Testosterone and Testopel, which some plaintiffs argue are…
More Top Stories
Three plaintiffs have been awarded a combined total of more than $1.5 billion after filing Roundup lawsuits over their non-Hodgkin's lymphoma diagnoses.
A federal judge has given plaintiffs' attorneys until November 17 to apply for leadership positions in coordinated Uber sexual assault lawsuits.
A federal judge is allowing hair relaxer lawsuits to move forward after rejecting a motion by manufacturers to have the cases thrown out.